Paclitaxel tumor biodistribution and efficacy after intratumoral injection of a biodegradable extended release implant

International Journal of Pharmaceutics

Volumn 358, Issue 1-2, 2008, Pages 114-120

  Shikanov, Ariella ^a   Shikanov, Sergey ^b   Vaisman, Boris ^a   Golenser, Jacob ^a   Domb, Abraham J ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Anti tumor efficacy; Controlled release; Injectable biodegradable polymer; Paclitaxel; Poly(ester anhydride); Tumor distribution

Indexed keywords

PACLITAXEL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLADDER TUMOR; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG DISTRIBUTION; DRUG EFFICACY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; MOUSE; NECROSIS; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; CELL SURVIVAL; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DECANOIC ACIDS; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; INJECTIONS; MICE; MICE, INBRED C3H; NEOPLASMS, EXPERIMENTAL; PACLITAXEL; POLYMERS; RICINOLEIC ACIDS;

EID: 44449102033     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2008.02.028     Document Type: Article

References (28)

1. Au J.L.S., Jang S.H., Zheng J., Chen C.T., Song S., Hu L., and Wientjes M.G. Determinants of drug delivery and transport to solid tumors. J. Control. Release 74 (2001) 31-46
2. Chen F.A., Kuriakose M.A., Zhou M.X., DeLacure M.D., and Dunn R.L. Biodegradable polymer-mediated intratumoral delivery of cisplatin for treatment of human head and neck squamous cell carcinoma in a chimeric mouse model. Head Neck-J. Sci. Spec. Head Neck 25 (2003) 554-560
3. Coudore F., Authier N., Guillaume D., Beal A., Duroux E., and Fialip J. High-performance liquid chromatographic determination of paclitaxel in rat serum: application to a toxicokinetic study. J. Chromatogr. B 721 (1999) 317-320
4. Domb A.J., Elmalak O., Shastri V.R., Ta-shma Z., Masters D.M., Ringel I., Teomim D., and Langer R. Polyanhydrides. Drug Targeting and Delivery (1997), Hardwood Academic Publishers, Amsterdam
5. Dordunoo S.K., Oktaba A.M.C., Hunter W., Min W., Cruz T., and Burt H.M. Release of taxol from poly(epsilon-caprolactone) pastes: effect of water-soluble additives. J. Control. Release 44 (1997) 87-94
6. Gershkovich P., and Hoffman A. Uptake of lipophilic drugs by plasma derived isolated chylomicrons: linear correlation with intestinal lymphatic bioavailability. Eur. J. Pharm. Sci. 26 (2005) 394-404
7. Goldberg E.P., Hadba A.R., Almond B.A., and Marotta J.S. Intratumoral cancer chemotherapy and immunotherapy: opportunities for nonsystemic preoperative drug delivery. J. Pharm. Pharmacol. 54 (2002) 159-180
8. Hakkarainen M. Aliphatic polyesters: abiotic and biotic degradation and degradation products. Degradable Aliphatic Polyesters 157 (2002) 113-138
9. Jackson J.K., Gleave M.E., Yago V., Beraldi E., Hunter W.L., and Burt H.M. The suppression of human prostate tumor growth in mice by the injection of a slow-release polymeric paste formulation of paclitaxel. Cancer Res. 60 (2000) 4146-4151
10. Jain R.K. Delivery of molecular medicine to solid tumors. Science 271 (1996) 1079-1080
11. Jang S.H., Wientjes M.G., and Au J.L.S. Determinants of paclitaxel uptake, accumulation and retention in solid tumors. Inv. New Drugs 19 (2001) 113-123
12. Jordan M.A., Wendell K., Gardiner S., Derry W.B., Copp H., and Wilson L. Mitotic block induced in HeLa cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death. Cancer Res. 56 (1996) 816-825
13. Katti D.S., Lakshmi S., Langer R., and Laurencin C.T. Toxicity, biodegradation and elimination of polyanhydrides. Adv. Drug Del. Rev. 54 (2002) 933-961
14. Kim S.C., Yu J., Lee J.W., Park E.S., and Chi S.C. Sensitive HPLC method for quantitation of paclitaxel (Genexol (R)) in biological samples with application to preclinical pharmacokinetics and biodistribution. J. Pharm. Biol. Anal. 39 (2005) 170-176
15. Krasko M.Y., Shikanov A., Ezra A., and Domb A.J. Poly(ester anhydride)s prepared by the insertion of ricinoleic acid into poly(sebacic acid). J. Polym. Sci. Pol. Chem. 41 (2003) 1059-1069
16. Kuh H.J., Jang S.H., Wientjes M.G., Weaver J.R., and Au J.L.S. Determinants of paclitaxel penetration and accumulation in human solid tumor. J. Pharm. Exp. Ther. 290 (1999) 871-880
17. Langer R. Biomaterials in drug delivery and tissue engineering: one laboratory's experience. Acc. Chem. Res. 33 (2000) 94-101
18. Nativ O., Aronson M., Medalia O., Moldavsky T., Sabo E., Ringel I., and Kravtsov V. Anti-neoplastic activity of paclitaxel on experimental superficial bladder cancer: in vivo and in vitro studies. Int. J. Cancer 70 (1997) 297-301
19. Ruel-Gariepy E., Shive M., Bichara A., Berrada M., Le Garrec D., Chenite A., and Leroux J.C. A thermosensitive chitosan-based hydrogel for the local delivery of paclitaxel. Eur. J. Pharm. Biopharm. 57 (2004) 53-63
20. Shikanov A., and Domb A.J. Poly(sebacic acid-co-ricinoleic acid) biodegradable injectable in situ gelling polymer. Biomacromolecules 7 (2006) 288-296
21. Song D., and Au J.L.S. Isocratic high-performance liquid-chromatographic assay of taxol in biological-fluids and tissues using automated column-switching. J. Chromatogr. B: Biomed. Appl. 663 (1995) 337-344
22. Stephens D., Li L., Robinson D., Chen S., Chang H.C., Liu R.M., Tian Y.Q., Ginsburg E.J., Gao X.Y., and Stultz T. Investigation of the in vitro release of gentamicin from a polyanhydride matrix. J. Control. Release 63 (2000) 305-317
23. Teomim D., and Domb A.J. Fatty acid terminated polyanhydrides. J. Polym. Sci. Pol. Chem. 37 (1999) 3337-3344
24. Teomim D., Nyska A., and Domb A.J. Ricinoleic acid-based biopolymers. J. Biomed. Mater. Res. 45 (1999) 258-267
25. Terwogt J.M.M., Nuijen B., Huinink W.W.T., and Beijnen J.H. Alternative formulations of paclitaxel. Cancer Treat. Rev. 23 (1997) 87-95
26. Tommasi S., Mangia A., Lacalamita R., Bellizzi A., Fedele V., Chiriatti A., Thomssen C., Kendzierski N., Latorre A., Lorusso V., Schittulli F., Zito F., Kavallaris M., and Paradiso A. Cytoskeleton and paclitaxel sensitivity in breast cancer: the role of beta-tubulins. Int. J. Cancer 120 (2007) 2078-2085
27. Walter K.A., Tamargo R.J., Olivi A., Burger P.C., and Brem H. Intratumoral chemotherapy. Neurosurgery 37 (1995) 1129-1145
28. Zamboni W.C., Gervais A.C., Egorin M.J., Schellens J.H.M., Delauter B.J., Zuhowski E.G., Pluim D., Hamburger D.R., Working P.K., Colbern G., and Eiseman J.L. Disposition of platinum (Pt) in B16 murine melanoma tumors after administration of cisplatin or pegylated liposomal-cisplatin formulations (SPI-077 and SPI-077B103). Clin. Cancer Res. 6 (2000) 4492S